Estimation of the physiologic ability and surgical stress scoring system as a useful predictor of postoperative recurrence in patients with stage II colorectal cancer: a multicenter study-Reference-Cited by-同舟云学术

Estimation of the physiologic ability and surgical stress scoring system as a useful predictor of postoperative recurrence in patients with stage II colorectal cancer: a multicenter study

Published:2023-02-15 Issue:8 Volume:53 Page:949-956
ISSN:0941-1291
Container-title:Surgery Today
language:en
Short-container-title:Surg Today

Author:

Tanio Akimitsu,Saito Hiroaki,Hara Kazushi,Sugezawa Ken,Uejima Chihiro,Kihara Kyoichi,Tatebe Shigeru,Kurisu Yasuro,Shibata Shunsuke,Yamamoto Toshio,Nishie Hiroshi,Shiota Setsujo,Naka Takuji,Sugamura Kenji,Katano Kuniyuki,Yamamoto Manabu,Fujiwara Yoshiyuki

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00595-023-02656-2.pdf

Reference21 articles.

1. Benson AB III, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22:3408–19.

2. Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A, ESMO Guidelines Working Group. Primary colon cancer: ESMO clinical practice guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2010;21:v70-7.

3. Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DS, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer. 2011;47:2633–41.

4. Inamoto S, Kawada K, Okamura R, Hida K, Sakai Y. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study. Int J Colorectal Dis. 2019;34:1303–15.

5. Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K. Prognostic significance of the preoperative ratio of C-reactive protein to albumin in patients with colorectal cancer. Anticancer Res. 2016;36:995–1001.